About EpigenetiXX ™ LLC
Our Company
EpigenetiXX™ LLC is a health science and technology company dedicated to advancing the field of epigenetic nutrition through evidence-based education, innovative digital tools, and practical solutions that empower healthier lives.
Our Mission
EpigenetiXX™ LLC is dedicated to making the science of epigenetics understandable, practical, and accessible to everyone. Our mission is to translate advances in epigenetics, nutrition, and microbiome science into evidence-based tools that empower individuals to improve their health through informed dietary and lifestyle choices.
Our primary focus is Epigenetic Nutrition—the science of how food and the gut microbiome influence gene expression without altering DNA. By integrating discoveries from molecular biology, nutritional science, and microbiome research, we develop practical educational resources and intelligent digital tools that enable individuals to make healthier decisions every day.
Our first publication, Epigenetic Nutrition©: Reducing the Risk of Early-Onset Colorectal Cancer, presents a new scientific framework for reducing the risk of early-onset colorectal cancer. The book explains how diet shapes the gut microbiome, how microbial metabolites regulate epigenetic pathways within colon cells, and how these interactions help maintain normal cellular function and support colon health. Complementing the book is the EpiMobile© Decision Support System, an intelligent software platform designed to transform scientific knowledge into practical daily guidance. The platform helps users plan meals, evaluate the epigenetic quality of foods, identify microbiome-supportive dietary patterns, and make healthier choices while grocery shopping or dining out. As the platform evolves, it will incorporate personalized recommendations and artificial intelligence to deliver individualized nutrition guidance based on the latest scientific evidence.
EpigenetiXX™ LLC is building a comprehensive ecosystem that combines authoritative publications, educational content, and innovative software into a single platform for Epigenetic Nutrition. Our goal is to bridge the gap between scientific discovery and everyday decision-making, making the principles of epigenetics practical, understandable, and actionable.
Future publications will extend this evidence-based approach to additional health challenges influenced by nutrition and epigenetics. The next title in development, Epigenetic Nutrition©: Preventing Sarcopenia in Older Adults, explores how targeted nutritional strategies can influence the epigenetic pathways that regulate muscle maintenance, strength, and healthy aging.
Our long-term vision is for Epigenetixx LLC to become the leading global authority in Epigenetic Nutrition—providing trusted education, innovative digital tools, and practical solutions that empower people to use food as a means of optimizing gene expression, preventing chronic disease, and promoting lifelong health.
Meet Our Founder
Martin J. Coyne, MD, MMI is the Founder and Chief Medical Officer of EpigenetiXX™ LLC, a health science and technology company dedicated to advancing the emerging field of Epigenetic Nutrition©. As a practicing gastroenterologist with decades of clinical experience, Dr. Coyne has devoted his career to understanding the relationship between nutrition, the gut microbiome, and chronic disease.
Throughout his years caring for patients, Dr. Coyne witnessed the growing burden of preventable chronic illnesses, particularly the alarming rise in early-onset colorectal cancer among younger adults. While modern medicine has made remarkable advances in diagnosis and treatment, he became increasingly convinced that preventing disease requires a deeper understanding of how everyday dietary choices influence human biology long before symptoms develop.
This conviction led him to develop the scientific framework of Epigenetic Nutrition©—an evidence-based approach that views food not simply as fuel, but as biological information. Through interactions with the gut microbiome, nutrients and naturally occurring plant compounds generate metabolic signals that influence epigenetic pathways regulating gene expression. These mechanisms help determine how our genes respond to the environment and play an important role in maintaining health throughout life.
Recognizing that scientific discoveries are only valuable when they can be applied in everyday life, Dr. Coyne founded EpigenetiXX™ to bridge the gap between research and practical decision-making. The company’s mission is to translate complex science into clear educational resources and innovative digital technologies that empower individuals to make healthier food choices with confidence.
Dr. Coyne is the author of the Epigenetic Nutrition© book series and leads the development of the EpiMobile© Support System, an AI-driven digital platform designed to help consumers apply the principles of Epigenetic Nutrition© while shopping, preparing meals, and dining out. By combining scientific evidence with artificial intelligence, EpigenetiXX™ aims to make personalized nutrition guidance accessible wherever food decisions are made.
Looking toward the future, Dr. Coyne envisions EpigenetiXX™ becoming a global leader in evidence-based nutritional science—helping individuals, healthcare professionals, and organizations harness the power of nutrition, the microbiome, and epigenetics to reduce disease risk, optimize health, and improve quality of life.
“My goal has always been to transform scientific discovery into practical tools that help people take control of their health. Every meal is an opportunity to send beneficial signals to our genes. By understanding those signals, we can move from simply treating disease to helping prevent it.”